Incidence, Mitigation, and Management of Neurologic Adverse Events in the CARTITUDE-2 Study of Patients with Multiple Myeloma Treated with Ciltacabtagene Autoleucel (Cilta-Cel)

Jakubowiak, A; Parekh, S; Madduri, D; Santomasso, B; Perez-Larraya, JG; van de Donk, NWCJ; Arnulf, B; Mateos, MV; De Braganca, KC; Varsos, H; Carrasco-Alfonso, MJ; Akram, M; Lendvai, N; Jackson, CC; Olyslager, Y; Zudaire, E; Li, C; Geng, D; Einsele, H; Cohen, A

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021; 21 (): S421

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索